Asset
RALINEPAG
United Therapeutics Corporation Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02279160 | phase2 | completed | 2014-12-01 | 2017-06-01 | United Therapeutics | Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension |
FDA applications (0)
This company has no applications containing this asset.